Moherin

莫海林

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMoherin
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsHyperlipidemiasAtherosclerosisCoronary Disease +[4] 
Global Approved IndicationsHyperlipidemiasAtherosclerosisCoronary Disease +[4] 
Approved Indications in ChinaHyperlipidemiasAtherosclerosisCoronary Disease +[4] 
Original Approved Country/TerritoryMainland China
Original Approved Date1999/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsHyperlipidemiasAtherosclerosisCoronary Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A